Spiramycin

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Spiramycin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Spiramycin: not commercially available in the US.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treatment of primary toxoplasmosis in pregnant women in order to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. J. Remington’s lab 650-326-8120).

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: October 24, 2016

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Spiramycin ID - 540513 A1 - Dzintars,Kathryn,Pharm.D., BCPS AU - Pham,Paul,Pharm.D. Y1 - 2016/10/24/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540513/all/Spiramycin PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -